Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2019
Price : $35 *
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors The Jackson Laboratory
- 25 Feb 2019 Planned End Date changed from 1 Apr 2021 to 29 Apr 2020.
- 25 Feb 2019 Planned primary completion date changed from 1 Apr 2021 to 29 Dec 2019.
- 25 Feb 2019 Status changed from recruiting to active, no longer recruiting.